Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | Clinical Neuroscience | Best Researcher Award

Assist. Prof. Dr. Chahra Chbili | University of Sousse | Tunisia

Dr. Chahra Chbili is an Assistant Professor of Pharmacology at the Higher School of Health Sciences and Techniques of Sousse (ESSTSS) and a member of the Research Laboratory of Metabolic Biophysics and Applied Pharmacology (LR/12ES02) at the Faculty of Medicine Ibn El Jazzar of Sousse, Tunisia. Her academic journey spans extensive training in biological sciences, genetics, and medical biotechnology, with a Ph.D. earned with highest honors for her work on the pharmacokinetic and pharmacogenetic study of carbamazepine therapy in epileptic and bipolar patients. Dr. Chbili’s research focuses on pharmacogenetics, pharmacokinetics, and the molecular mechanisms underlying drug efficacy and toxicity. She has contributed significantly to studies exploring the genetic determinants of drug metabolism, including investigations into glutathione-S-transferases in tuberculosis patients with drug-induced hepatotoxicity. Skilled in advanced laboratory techniques such as PCR, FISH, ELISA, and HPLC-MS, she has developed expertise in integrating molecular biology with clinical pharmacology. Dr. Chbili has authored 17 scientific documents, accumulated 138 citations across 123 indexed works, and maintains an h-index of 7, reflecting her impactful contributions to pharmacological and biomedical research in Tunisia and beyond.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

Chbili, C., Mrad, S., Graiet, H., Selmi, M., Maatoug, J., Maoua, M., Abdellaoui, L., Mrizek, N., Nouira, M., Ben Fredj, M., et al. (2024). Randomized, placebo-controlled pilot study investigating the effects of Laurus nobilis tea on lipid profiles and oxidative stress biomarkers in healthy North African volunteers. The North African Journal of Food and Nutrition Research, 8(17), 86–98.

Chbili, C., Fathallah, N., Laadhari, C., Ouni, B., Saguem, S., Ben Fredj, M., Abdelghani, A., Ben Saad, H., & Ben Salem, C. (2022). Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study. Gene, 808, 146019.

Rebai, A., Chbili, C., Ben Amor, S., Hassine, A., Ben Ammou, S., & Saguem, S. (2021). Effects of glutathione S-transferase M1 and T1 deletions on Parkinson’s disease risk among a North African population. Revue Neurologique, 177(1–2), 93–99.

Chbili, C. (2021, August 22). The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson’s disease: A randomized controlled pilot study. Journal article.

Chbili, C., Maoua, M., Selmi, M., Mrad, S., Khairi, H., Limem, K., Mrizek, N., Saguem, S., & Ben Fredj, M. (2020). Evaluation of daily Laurus nobilis tea consumption on lipid profile biomarkers in healthy volunteers. Journal of the American College of Nutrition, 39(6), 518–526.

Rebai, A., Reçber, T., Nemutlu, E., Chbili, C., Kurbanoglu, S., Kir, S., Ben Amor, S., Özkan, S. A., & Saguem, S. (2020). GC-MS based metabolic profiling of Parkinson’s disease with glutathione S-transferase M1 and T1 polymorphism in Tunisian patients. Combinatorial Chemistry and High Throughput Screening, 23(8), 785–794.

Lin Xiao | Cellular Neuroscience | Best Researcher Award

Dr. Lin Xiao | Cellular Neuroscience | Best Researcher Award

Dr. Lin Xiao | Institute for Brain Research and Rehabilitation | China

Dr. Lin Xiao is a distinguished Professor of Neuroscience at the Institute for Brain Research and Rehabilitation, South China Normal University, whose pioneering research has significantly advanced understanding of oligodendrocyte biology and myelin plasticity. His work elucidates the mechanisms by which adaptive myelination contributes to motor learning and memory, proposing a novel “biphasic plasticity model” that distinguishes distinct phases of learning and consolidation. Dr. Xiao’s research has been published in leading journals including Nature Neuroscience, Science, Nature Communications, and Advanced Science, collectively garnering over 2,800 citations and an h-index of 28, with approximately 20 peer-reviewed articles. His landmark paper in Nature Neuroscience has become a classic reference with over 500 citations, demonstrating substantial influence in the field. He has led multiple projects funded by the National Natural Science Foundation of China, including completed and ongoing studies, and established major collaborations with institutions such as University College London. His research areas include glial–neuron interactions, mechanisms of remyelination, neurodevelopmental disorders such as autism, and psychiatric disorders including depression. These contributions have been recognized with national awards and have opened promising avenues for therapeutic strategies in demyelinating and cognitive disorders.

Profiles: Google Scholar | Orcid | Research Gate  

Featured Publications

Marques, S., Zeisel, A., Codeluppi, S., Van Bruggen, D., Mendanha Falcão, A., et al. (2016). Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science, 352(6291), 1326–1329.

Xiao, L., Ohayon, D., McKenzie, I. A., Sinclair-Wilson, A., Wright, J. L., Fudge, A. D., et al. (2016). Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning. Nature Neuroscience, 19(9), 1210–1217.

Liu, S., Yu, M., He, Y., Xiao, L., Wang, F., Song, C., Sun, S., Ling, C., & Xu, Z. (2008). Melittin prevents liver cancer cell metastasis through inhibition of the Rac1‐dependent pathway. Hepatology, 47(6), 1964–1973.

Li, C., Xiao, L., Liu, X., Yang, W., Shen, W., Hu, C., Yang, G., & He, C. (2013). A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination. Glia, 61(5), 732–749.

Feng, P. A. N. (2003). Fast mode decision for intra prediction. JVT-G013, March 2003.

Li, Y. X., Ding, S. J., Xiao, L., Guo, W., & Zhan, Q. (2008). Desferoxamine preconditioning protects against cerebral ischemia in rats by inducing expressions of hypoxia inducible factor 1α and erythropoietin. Neuroscience Bulletin, 24(2), 89–95.

Mansoor Showkat | Computational Neuroscience | Best Researcher Award

Mr. Mansoor Showkat | Computational Neuroscience | Best Researcher Award

Mr. Mansoor Showkat | SKUAT-Kashmir | India

Mansoor Showkat is a researcher in Plant Biotechnology with an M.Sc. from the University of Agricultural Sciences, Bangalore, and a B.Sc. (Hons.) in Horticulture from Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir. His research expertise spans molecular biology, computational biology, bioinformatics, and tissue culture, with particular emphasis on antifungal compound analysis, gene transformation, and plant-pathogen interactions. Mansoor has contributed to several peer-reviewed publications and book chapters, focusing on the in-silico and in-vitro evaluation of bioactive compounds such as cordycepin, molecular mechanisms of stress responses, and secondary metabolite profiling in plants. His research projects include genetic transformation studies, metabolomics-based investigations, and the use of omics tools for crop improvement. He has actively participated in numerous international workshops, conferences, and webinars related to biotechnology, bioinformatics, and genomics. Mansoor has achieved significant academic recognition, including national rankings in competitive examinations by the Indian Council of Agricultural Research. His scientific impact is reflected by a citation count of 15, an h-index of 2, and an i10-index of 0, highlighting his growing contribution to molecular and agricultural biotechnology research.

Featured Publications

  1. Showkat, M., Narayanappa, N., Umashankar, N., & Saraswathy, B. P., et al. (2024). Optimization of fermentation conditions of Cordyceps militaris and in silico analysis of antifungal property of cordycepin against plant pathogens. Journal of Basic Microbiology, 64(10), e2400409.

  2. Fatimah, N., Ashraf, S., R. U., K. N., Anju, P. B., Showkat, M., Perveen, K., Bukhari, N. A., et al. (2024). Evaluation of suitability and biodegradability of the organophosphate insecticides to mitigate insecticide pollution in onion farming. Heliyon, 10(12).

  3. Margay, K. A. A. A. R., Ashraf, S., Fatimah, N., Jabeen, S. G., & Showkat, M., et al. (2024). Plant circadian clocks: Unravelling the molecular rhythms of nature. International Journal of Plant and Soil Science, 36(8), 596–617.

  4. Margay, A. R., Ashraf, S., Fatimah, N., Jabeen, S. G., Showkat, M., R. U., K. N., Gani, A., et al. (2024). Harnessing brassinosteroids for heat resilience in wheat: A comprehensive study.

  5. Showkat, M., Nagesha, N., Ashraf, S., Nayana, K., Bashir, S., Nair, A. S., et al. (2024). Cordycepin: A molecular Trojan horse against Fusarium oxysporum f. sp. cubense—A computational perspective.

Alireza Kamali-Asl | Neuroimaging | Best Researcher Award

Prof. Dr. Alireza Kamali-Asl | Neuroimaging | Best Researcher Award

Prof. Dr. Alireza Kamali-Asl | Freelance organization | United Kingdom

Professor Alireza Kamaliasl is a distinguished expert in medical radiation engineering and serves as the Director of the Medical Imaging Instruments Laboratory and Head of Molecular Imaging Modality. With over two decades of experience in healthcare technology and molecular imaging, he has made pioneering contributions to the design, simulation, and manufacture of advanced medical imaging instruments across modalities such as SPECT, PET, CT, and radiography. His interdisciplinary research integrates mathematical modeling, computational analysis, and clinical collaboration to enhance diagnostic and theranostic imaging systems. Professor Kamaliasl has authored more than 150 publications in top-tier international journals and conferences, achieving an h-index of 28, with over 3,800 citations and 160 research documents indexed in global databases. He has successfully supervised more than 45 postgraduate research projects, fostering innovation and leadership in radiological sciences. His expertise spans radio-isotopic imaging, system performance optimization, radiation shielding, device calibration, and preventive maintenance management. Recognized for his role as a visionary mentor and strategic planner, Professor Kamaliasl continues to advance multimodality molecular imaging and medical instrumentation, bridging the gap between engineering innovation and clinical application to improve diagnostic precision and therapeutic outcomes.

Profiles: Scopus | Orcid | Google Scholar | Research Gate | Linked In

Featured Publications

  1. Habibzadeh, M. A., Ay, M. R., Kamali-Asl, A. R., Ghadiri, H., & Zaidi, H. (2012). Impact of miscentering on patient dose and image noise in X-ray CT imaging: Phantom and clinical studies. Physica Medica, 28(3), 191–199.

  2. Aghakhan Olia, N., Kamali-Asl, A., Hariri Tabrizi, S., Geramifar, P., et al. (2022). Deep learning–based denoising of low-dose SPECT myocardial perfusion images: Quantitative assessment and clinical performance. European Journal of Nuclear Medicine and Molecular Imaging, 49(5), 1508–1522.

  3. Arefan, D., Talebpour, A., Ahmadinejhad, N., & Kamali-Asl, A. (2015). Automatic breast density classification using neural network. Journal of Instrumentation, 10(12), T12002.

  4. Poorbaygi, H., Aghamiri, S. M. R., Sheibani, S., Kamali-Asl, A., et al. (2011). Production of glass microspheres comprising 90Y and 177Lu for treating hepatic tumors with SPECT imaging capabilities. Applied Radiation and Isotopes, 69(10), 1407–1414.

  5. Khazaee Moghadam, M., Kamali-Asl, A., Geramifar, P., & Zaidi, H. (2016). Evaluating the application of tissue-specific dose kernels instead of water dose kernels in internal dosimetry: A Monte Carlo study. Cancer Biotherapy and Radiopharmaceuticals, 31(10), 367–379.*

Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Prof. Dr. Elzbieta Paszynska | Clinical Neuroscience | Best Research Article Award

Prof. Dr. Elzbieta Paszynska | Poznan University of Medical Sciences | Poland

Professor Elzbieta Paszynska is a distinguished expert in dentistry, serving as Chair of the Department of Integrated Dentistry and Chair of Community Dentistry at Poznan University of Medical Sciences. Her academic focus includes community dentistry, adult comprehensive dental treatment, dental materials, and clinical research in oral health, particularly in patients with eating disorders. She has led numerous significant research projects, including studies on salivary biomarkers, oral health status in eating disorders, and the caries-preventive effects of hydroxyapatite toothpaste in children and adults, collaborating with multiple international institutions. Her research has contributed to over 70 scientific documents with more than 598 citations and an h-index of 13. She has published high-impact works in journals such as Scientific Reports, Frontiers in Public Health, Frontiers in Psychiatry, Nutrients, and the Journal of Dentistry. Her contributions include interdisciplinary projects integrating dentistry, ethics, and public health, and she has coordinated large-scale EU-funded projects and international collaborations. Her work has been recognized with multiple institutional and national awards for scientific excellence, teaching, and professional contributions to dentistry, as well as honors from professional dental associations. She is an active member of national boards and promotes innovation in dental education and research.

Profiles: Scopus | Orcid | Research Gate

Featured Publications

  • Obesity and central accumulation of fat in school-age children with attention-deficit/hyperactivity disorder. (2025). Scientific Reports.

  • Miescher’s Cheilitis as a Diagnostic and Therapeutic Challenge—A Case Report. (2025). Medicina, Kaunas, Lithuania.

  • Prevalence of Toothache in Adults: A Meta-Analysis of Worldwide Studies. (2025).

  • Pain experience and behavior management: efficacy of photobiomodulation as an adjunct to local anesthesia in MIH patients—a randomized split-mouth clinical study. (2025). Frontiers in Neurology.

  • Clinical evidence of caries prevention by hydroxyapatite: An updated systematic review and meta-analysis. (2025).

Luay Rashan | Neuroscience of Pain and Analgesia | Best Researcher Award

Prof. Dr. Luay Rashan | Neuroscience of Pain and Analgesia | Best Researcher Award

Prof. Dr. Luay Rashan | Dhofar University | Oman

Professor Luay Jamil Rashan is a distinguished academic specializing in Histology and Histochemistry, currently serving as Director and Principal Investigator at the Research Center, Dhofar University, Oman. He holds a B.Sc. and M.Sc. from the University of Mosul, Iraq, and a Ph.D. from Trinity College, University of Dublin, Ireland, with extensive post-doctoral experience in pharmacognosy, virology, pharmacology, and plant biochemistry across leading institutions in Iraq, the UK, and Germany. Professor Rashan has authored 88 scholarly documents that have garnered over 1,103 citations, reflecting significant impact in his field, and holds an h-index of 19, underscoring his scholarly influence. His research contributions span histological and histochemical methodologies, pharmacological studies, and bio-organic chemistry, with a focus on advancing scientific understanding in tissue biology and drug evaluation. His work has been recognized internationally, reflecting a sustained commitment to research excellence, academic leadership, and interdisciplinary collaboration. As a prolific researcher, Professor Rashan continues to contribute to advancing knowledge through publications, mentoring, and leading innovative research initiatives that bridge experimental science with applied biomedical research. His career exemplifies a dedication to both scientific discovery and the development of future generations of researchers.

Profiles: Scopus | Google Scholar | Research Gate

Featured Publications

  • Author(s). (2025). Neuronutritional enhancement of antioxidant defense system through Nrf2/HO1/NQO1 axis in fibromyalgia. Neurochemistry International.

  • Author(s). (2025). Oleandrin-mediated suppression of MELK induces apoptosis, autophagy, and ferroptosis in human non-small cell lung cancer cells. Phytomedicine.

  • Author(s). (2025). Cannabis oil protects against valproic acid–induced autism spectrum disorder by reducing oxidative stress. Developmental Neurobiology.

  • Author(s). (2025). Profiling and bioactivity of polyphenols from the Omani medicinal plant Terminalia dhofarica (syn. Anogeissus dhofarica). Molecules Basel Switzerland.

  • Author(s). (2025). An updated review on pharmacological aspects and nanotechnological advancements of frankincense boswellic acids.

Hiroshi Nagase | Neuropharmacology | Best Researcher Award

Prof. Hiroshi Nagase | Neuropharmacology | Best Researcher Award

Prof. Hiroshi Nagase | University of Tsukuba | Japan

Prof. Hiroshi Nagase is a distinguished Japanese scientist recognized for his pioneering contributions to medicinal chemistry and drug discovery. He earned his B.S., M.S., and Ph.D. degrees in Chemistry from Nagoya University, Japan, and later served as a Visiting Scientist at the University of Minnesota’s Department of Medicinal Chemistry. Dr. Nagase began his professional career at Toray Industries Inc., where he advanced from Researcher to Director in the Basic Research Laboratories. He later joined Kitasato University’s School of Pharmacy as a Professor and subsequently served as a Principal Investigator and Professor at the International Institute for Integrative Sleep Medicine (IIIS) under the World Premier International Research Center Initiative at the University of Tsukuba, where he now holds the title of Professor Emeritus. His academic and research influence extended through adjunct professorships at the University of Tokyo, the University of Nagasaki, Toyohashi Polytechnic College, and Nagoya University. Dr. Nagase has authored 39 scientific documents, which have collectively garnered 279 citations from 189 sources, reflecting his substantial impact on the field. With an h-index of 10, his research continues to inspire advancements in medicinal chemistry, neuropharmacology, and therapeutic innovation.

Profiles: Scopus | Research Gate

Featured Publication

Nagase, H. (2025). Development of novel bioactive alkaloids based on specific reactions of the 4,5-epoxymorphinan framework. Synlett.

[Authors not listed]. (2025). Delta opioid receptor agonists activate PI3K–mTORC1 signaling in parvalbumin-positive interneurons in mouse infralimbic prefrontal cortex to exert acute antidepressant-like effects. Molecular Psychiatry.

Musawer Hakimi | Systems Neuroscience | Best Researcher Award

Mr. Musawer Hakimi | Systems Neuroscience | Best Researcher Award

Mr. Musawer Hakimi | Samangan University | Afghanistan

Mr. Musawer Hakimi is an accomplished Assistant Professor at Samangan University, specializing in Computer Science. He holds a Bachelor’s degree in Computer Science from India and a Master’s degree in Information Technology from Kabul University. Demonstrating a strong commitment to lifelong learning, he has earned 25 professional certificates in Computer Science from India, along with two specialized certifications in Ethical Hacking and Oracle Database from the United States. His academic excellence and research contributions have positioned him as a respected scholar with 3 published documents, 13 citations, and an h-index of 1. Mr. Hakimi’s scholarly work has been featured in reputable international journals across the United Kingdom, the United States, Turkey, Sweden, and Indonesia, reflecting his active engagement in global research networks. Beyond his research achievements, he is dedicated to nurturing future computer scientists through his teaching and mentorship at the Public University of Afghanistan, where he plays an instrumental role in advancing computer science education. His interdisciplinary expertise, international collaborations, and consistent scholarly output underscore his impact as an educator, researcher, and thought leader in the evolving field of computer science, contributing to the growth of academic excellence and innovation within Afghanistan and the broader global academic community.

Profiles: Scopus | Orcid | Google Scholar | Research Gate

Featured Publications

Quraishi, T., Ulusi, H., Muhid, A., Hakimi, M., & Olusi, M. R. (2024). Empowering students through digital literacy: A case study of successful integration in a higher education curriculum. Journal of Digital Learning and Distance Education, 2(9), 667–681.

Fazil, A. W., Hakimi, M., Shahidzay, A. K., & Hasas, A. (2024). Exploring the broad impact of AI technologies on student engagement and academic performance in university settings in Afghanistan. RIGGS: Journal of Artificial Intelligence and Digital Business, 2(2), 56–63.

Hakimi, M., Katebzadah, S., & Fazil, A. W. (2024). Comprehensive insights into e-learning in contemporary education: Analyzing trends, challenges, and best practices. Journal of Education and Teaching Learning (JETL), 6(1), 86–105.

Hakimi, N., Hakimi, M., Hejran, M., Quraishi, T., Qasemi, P., Ahmadi, L., & others. (2024). Challenges and opportunities of e-learning for women’s education in developing countries: Insights from Women Online University. EDUTREND: Journal of Emerging Issues and Trends in Education, 1(1), 57–69.

Hasas, A., Hakimi, M., Shahidzay, A. K., & Fazil, A. W. (2024). AI for social good: Leveraging artificial intelligence for community development. Journal of Community Service and Society Empowerment, 2(2), 196–210.

Fazil, A. W., Hakimi, M., Sajid, S., Quchi, M. M., & Khaliqyar, K. Q. (2023). Enhancing internet safety and cybersecurity awareness among secondary and high school students in Afghanistan: A case study of Badakhshan Province. American Journal of Education and Technology, 2(4), 50–61.

Alam, M. I., Khatri, S., Shukla, D. K., Misra, N. K., Satpathy, S., & Hakimi, M. (2025). Blockchain-based coal supply chain management system for thermal power plants. Discover Computing, 28(1), 1–32.

Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Ms. Priyadharshini Veeralakshmanan | Clinical Neuroscience | Best Researcher Award

Ms. Priyadharshini Veeralakshmanan | Amrita Vishwa Vidyapeetham | India

Ms. Priyadharshini Veeralakshmanan is a dedicated PhD scholar at Amrita Vishwa Vidyapeetham, specializing in Medical Oncology with a focus on Breast Cancer Immunology and the immunosuppressive tumour microenvironment (TME), particularly in Triple-Negative Breast Cancer (TNBC). Her doctoral research involves a Phase 2/3 open-label pilot clinical trial to evaluate neoadjuvant metronomic chemotherapy for modulating the TME and enhancing chemo- and immunotherapy responses, quantifying immunosuppressive cells and tumour-infiltrating lymphocytes from blood and tumour tissue. She holds an M.Sc. in Physician Assistant (Medical Oncology) and a B.Sc. in Physician Assistant (General Medicine), with extensive clinical training in oncology, hematology, surgical oncology, radiation oncology, and palliative care. Priyadharshini has strong expertise in flow cytometry, cell culture, in vitro drug testing, cytotoxicity assays, systematic reviews, meta-analysis, and clinical trial design, using advanced analytical tools such as FlowJo, SPSS, and GraphPad Prism. She has authored several publications, with an h-index of 3, over 7 documents, and more than 50 citations. A member of ESMO, ASCO, and I-OSI, she is committed to advancing cancer research, translating innovative findings into clinical practice to improve patient outcomes globally.

Profiles: Orcid | Linked In

Featured publications

Veeralakshmanan, P., Jose, W. M., Udayakumaran, S., Bindhu, M. R., Dutta, D., Rajesh, K., Kavalagunta, S., Bhaskaran, R., Haridas, N. K., Rakesh, M. P., et al. (2025). Multimodal management and outcome of pediatric and adolescent malignant central nervous system tumors: A single‐center retrospective study. Malignancy Spectrum.

Surendran, H. P., Sah, S. K., Veeralakshmanan, P., Nair, P., Ashok, H. P., Unnikrishnan, M. K., Kalavagunta, S., Sasidharan, A., Chandran, D., Poornachary, N. M., et al. (2025). Efficacy of hippocampal avoidance whole brain radiotherapy to preserve the cognitive functions among brain metastasis patients: Systematic review and meta-analysis. Neurology India, 73(5), 715–725.

Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | University of California San Diego | United States

Dr. Irene Litvan, MD, is the Tasch Endowed Professor of Neurology and Director of the Parkinson and Other Movement Disorders Center at the University of California, San Diego. She is internationally recognized for her pioneering work in movement disorders, particularly Parkinson’s disease and related neurodegenerative conditions. As a leading clinician-scientist, she has directed major multicenter and international initiatives to develop clinical and neuropathologic diagnostic criteria, identify disease biomarkers, and advance therapeutic interventions. Her extensive research spans epidemiologic, genetic, and clinico-pathologic correlation studies that have significantly deepened the understanding of movement disorders. Dr. Litvan’s scholarly impact is reflected in 6 published documents, 10 citations, and an h-index of 1. Throughout her distinguished career, she has received consistent funding support from national and international agencies, industry collaborations, and philanthropic organizations. Beyond her research, she has served as a dedicated mentor, shaping the next generation of neurologists and neuroscientists. Dr. Litvan also leads the UC San Diego Parkinson and Other Movement Disorders Center, fostering clinical excellence and research innovation aimed at improving diagnosis, management, and quality of life for individuals with Parkinson’s disease and other movement-related neurological disorders.

Featured Publications

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626.

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS–SPSP international workshop. Neurology, 47(1), 1–9.

Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Movement Disorders, 32(6), 853–864.